---
title: "Glucotoxicity Drives Ribosome Remodeling and Impairs Beta-Cell Insulin Production"
id: "biorxiv-2-ribosome-remodeling-under-glucotoxic-conditions-impairs-beta-cell-function"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-2-ribosome-remodeling-under-glucotoxic-conditions-impairs-beta-cell-function"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1?rss=1"
published_at: "2026-11-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Glucotoxicity Drives Ribosome Remodeling and Impairs Beta-Cell Insulin Production
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-2-ribosome-remodeling-under-glucotoxic-conditions-impairs-beta-cell-function
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1?rss=1)
- **Published At:** 2026-11-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators used quantitative mass spectrometry on actively translating ribosomes isolated from MIN6 cells to compare control and glucotoxic conditions. - Data indicated sustained high glucose selectively decreased the ribosomal lateral stalk subunit **RPLP1** on translating ribosomes. - The study team performed RPLP1 knockdown in MIN6 cells and in primary islets; this manipulation reduced translation of **insulin** and impaired glucose-stimulated insulin secretion. - Depletion of **RPLP1** in vivo resulted in glucose intolerance in the model used. - Authors propose a mechanism linking metabolic overload to selective mRNA translation defects in **beta-cell** dysfunction. - The preprint has not been peer reviewed; the authors disclosed a pending patent related to the findings. - The source did not report detailed experimental parameters such as glucose exposure durations, knockdown methods or in vivo model specifics in the abstract; those methodological details were not provided in the abstract and therefore are not summarized here.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=VdKI2pCpHCeQrG3EepZnNQ1BDBDfio9c5u9rIKMBCGM-1794580472.0456455-1.2.1.1-S.ab5GiydYGuX9bsxQvf3YT.rKVdWbO7EgDn9CA60CV.ULf2tc24CBkmDncEsadf) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Ribosome remodeling under glucotoxic conditions impairs beta-cell function Abigael Cheruiyot Harvey, Jose Santos Navarro Arriola, Olasubomi Akintola, Ly Nguyen, Jennifer Hollister-Lock, Kanako Iwasaki, Susan Bonner-Weir, Cristina Aguayo-Mazzucato, Jean E Schaffer doi: https://doi.org/10.64898/2026.11.11.765979 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Abigael Cheruiyot Harvey Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Abigael%2BCheruiyot%2BHarvey%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Harvey%20AC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAbigael%2BCheruiyot%2BHarvey%2B) Jose Santos Navarro Arriola Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jose%2BSantos%2BNavarro%2BArriola%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Arriola%20JS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJose%2BSantos%2BNavarro%2BArriola%2B) Olasubomi Akintola Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Olasubomi%2BAkintola%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Akintola%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AOlasubomi%2BAkintola%2B) Ly Nguyen Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ly%2BNguyen%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Nguyen%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALy%2BNguyen%2B) Jennifer Hollister-Lock Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jennifer%2BHollister-Lock%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hollister-Lock%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJennifer%2BHollister-Lock%2B) Kanako Iwasaki Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kanako%2BIwasaki%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Iwasaki%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AKanako%2BIwasaki%2B) Susan Bonner-Weir Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Susan%2BBonner-Weir%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Bonner-Weir%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASusan%2BBonner-Weir%2B) Cristina Aguayo-Mazzucato Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Cristina%2BAguayo-Mazzucato%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Aguayo-Mazzucato%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ACristina%2BAguayo-Mazzucato%2B) Jean E Schaffer Joslin Diabetes Center * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jean%2BE%2BSchaffer%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Schaffer%20JE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJean%2BE%2BSchaffer%2B) * For correspondence: jean.schaffer@joslin.harvard.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5958436/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5958436/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5958436/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5958436/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5958436/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Diabetes develops when pancreatic beta-cells fail to secrete sufficient insulin to meet metabolic demand. Chronic hyperglycemia accelerates beta-cell failure and dysregulates mRNA translation before the onset of endoplasmic reticulum stress, but the underlying mechanisms remain unknown. Here, quantitative mass spectrometry of translating ribosomes isolated from MIN6 cells under control and glucotoxic conditions revealed that sustained high glucose remodels ribosome composition by selectively decreasing Ribosomal Protein Lateral Stalk Subunit P1 (RPLP1) on actively translating ribosomes. Knockdown of RPLP1 in MIN6 cells and in primary islets reduced translation of insulin and impaired glucose-stimulated insulin secretion. Depletion of RPLP1 in vivo led to glucose intolerance. Together, our findings indicate that glucotoxicity remodels beta-cell ribosomes, leading to selective mRNA translation impairment and decreased insulin secretion. This previously unrecognized mechanism linking metabolic overload to beta-cell dysfunction suggests that preserving RPLP1 association with ribosomes could represent a therapeutic strategy for maintaining beta-cell function in diabetes. ### Competing Interest Statement ACH and JES are inventors on a pending patent based on findings reported in this manuscript (United States patent 01123-0024-60US, filed 09/21/2026). ## Funder Information Declared NIH, R01DK138605, DP1DK119141, K99DK140526, R01DK132535, P30DK036836 Beatson Foundation, 2022-005 NSF, DGE21240743 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.1101/2025.10.07.681022v2 "6S RNA tunes virulence, surface immunogenicity, and phenotypic heterogeneity in tissue-invading Yersinia") Posted November 13, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/13/2026.11.11.765979.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.11.765979v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Ribosome remodeling under glucotoxic conditions impairs beta-cell function Abigael Cheruiyot Harvey, Jose Santos Navarro Arriola, Olasubomi Akintola, Ly Nguyen, Jennifer Hollister-Lock, Kanako Iwasaki, Susan Bonner-Weir, Cristina Aguayo-Mazzucato, Jean E Schaffer bioRxiv 2026.11.11.765979; doi: https://doi.org/10.64898/2026.11.11.765979 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765979v1%26text%3DRibosome%2520remodeling%2520under%2520glucotoxic%2520conditions%2520impairs%2520beta-cell%2520function "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765979v1%26t%3DRibosome%2520remodeling%2520under%2520glucotoxic%2520conditions%2520impairs%2520beta-cell%2520function "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765979v1%26title%3DRibosome%2520remodeling%2520under%2520glucotoxic%2520conditions%2520impairs%2520beta-cell%2520function%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765979v1%26title%3DRibosome%2520remodeling%2520under%2520glucotoxic%2520conditions%2520impairs%2520beta-cell%2520function "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.11.765979v1&count=horizontal&via=&text=Ribosome%20remo
## Related Clinical Research

- [Myeloid mDIC (SLC25A10) Loss Reprograms Adipose Macrophages and Improves Metabolism in Obesity](https://medichelpline.com/clinical-feed/biorxiv-11-myeloid-mdic-deficiency-remodels-adipose-macrophages-to-an-efferocytosis.md)
- [Later bedtimes and late eating tied to higher metabolic syndrome risk](https://medichelpline.com/clinical-feed/medical-news-today-0-eating-and-sleeping-later-associated-with-increased-health-risks.md)
- [Olive oil before carbs and blood sugar: what the mouse study found](https://medichelpline.com/clinical-feed/medical-news-today-0-olive-oil-shot-trend-what-science-really-says-about-fat-and-glucose-response.md)
- [Nonlinear association of sleep quality (PSQI) with type 2 diabetes prevalence in community chronic](https://medichelpline.com/clinical-feed/plos-one-18-nonlinear-relationship-between-sleep-quality-and-prevalence-of-type-2-diabetes.md)
- [GLP-1 receptor agonists and reduced dementia risk in patients with CKD and type 2 diabetes](https://medichelpline.com/clinical-feed/pubmed-41697144.md) (DOI: 10.1093/ndt/gfag032)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.